PAA.AX
Price:
$0.23
Market Cap:
$111.93M
PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of cancer. The company also provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries worldwide. The company has a research agreement with the Walter and Eliza Hall Institute to investigate the effects of MPL upon human T-lymphotrophic virus-1 ...[Read more]
Industry
Biotechnology
IPO Date
2001-10-05
Stock Exchange
ASX
Ticker
PAA.AX
According to PharmAust Limited’s latest financial reports and current stock price. The company's current PE Ratio is -11.50. This represents a change of -82.93% compared to the average of -67.36 of the last 4 quarters.
The mean historical PE Ratio of PharmAust Limited over the last ten years is -9.95. The current -11.50 PE Ratio has changed 11.46% with respect to the historical average. Over the past ten years (40 quarters), PAA.AX's PE Ratio was at its highest in in the June 2016 quarter at -0.57. The PE Ratio was at its lowest in in the December 2022 quarter at -239.36.
Average
-9.95
Median
-5.39
Minimum
-33.69
Maximum
-1.71
Discovering the peaks and valleys of PharmAust Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 495.68%
Maximum Annual PE Ratio = -1.71
Minimum Annual Increase = -70.15%
Minimum Annual PE Ratio = -33.69
Year | PE Ratio | Change |
---|---|---|
2024 | -8.01 | 106.54% |
2023 | -3.88 | -70.15% |
2022 | -12.99 | -39.56% |
2021 | -21.49 | -36.23% |
2020 | -33.69 | 495.68% |
2019 | -5.66 | 161.54% |
2018 | -2.16 | -57.86% |
2017 | -5.13 | 200.39% |
2016 | -1.71 | -64.56% |
2015 | -4.82 | -50.39% |
The current PE Ratio of PharmAust Limited (PAA.AX) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-8.29
5-year avg
-16.01
10-year avg
-9.95
PharmAust Limited’s PE Ratio is less than Patrys Limited (-1.74), greater than PYC Therapeutics Limited (-138.70), less than Biotron Limited (-4.46), less than Pharmaxis Ltd (-2.15), less than Antisense Therapeutics Limited (0),
Company | PE Ratio | Market cap |
---|---|---|
-1.74 | $6.17M | |
-138.70 | $597.26M | |
-4.46 | $15.34M | |
-2.15 | $20.23M | |
0 | $52.29M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PharmAust Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PharmAust Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is PharmAust Limited's PE Ratio?
How is the PE Ratio calculated for PharmAust Limited (PAA.AX)?
What is the highest PE Ratio for PharmAust Limited (PAA.AX)?
What is the 3-year average PE Ratio for PharmAust Limited (PAA.AX)?
What is the 5-year average PE Ratio for PharmAust Limited (PAA.AX)?
How does the current PE Ratio for PharmAust Limited (PAA.AX) compare to its historical average?